Integrating plasma next-generation sequencing (NGS) alongside tissue testing when determining lung cancer diagnosis may improve outcomes for patients. Carrying out plasma next-generation sequencing ...
Labcorp Oncology, Director, Medical Affairs and Adjunct Assistant Professor, Duke University Medical Center, Duke Cancer Institute, Department of Obstetrics & Gynecology, Division of Gynecologic ...
The largest study to date to assess the clinical value of concurrently testing tissue and circulating tumour DNA (ctDNA), highlights the usefulness of this dual approach for identifying targetable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback